‌

US Patent 10774343 MND promoter chimeric antigen receptors

Patent 10774343 was granted and assigned to Bluebird Bio on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

September 15, 2020

Patent Application Number

15306724

Date Filed

April 24, 2015

Patent Citations

US Patent 10639358 BCMA chimeric antigen receptors

US Patent 10646558 BCMA chimeric antigen receptors

US Patent 10383929 BCMA chimeric antigen receptors

US Patent 10479975 Methods of making T cell compositions

US Patent 10624960 BCMA chimeric antigen receptors

US Patent 10639359 BCMA chimeric antigen receptors

Patent Citations Received

US Patent 11479755 T cell compositions

US Patent 11976084 Spiropyrrolidine derived antiviral agents

0

US Patent 12006369 BCMA chimeric antigen receptors

0

US Patent 12109234 Anti-BCMA CAR T cell compositions

0

US Patent 11560547 Methods of making T cell compositions

US Patent 11020466 BCMA chimeric antigen receptors

US Patent 11633463 BCMA chimeric antigen receptors

0

US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents

...

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10774343 MND promoter chimeric antigen receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.